Education
About Us
Working with TipRanks
Follow Us
DSTL - ETF AI Analysis
Top Page
Distillate US Fundamental Stability & Value ETF (DSTL)
Rating:71Outperform
Price Target:
$63.00
Positive Factors
Strong Top Holdings
Several top positions, such as Johnson & Johnson and AbbVie, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors like Health Care, Technology, and Industrials, reducing reliance on any single industry.
Reasonable Expense Ratio
The fund's expense ratio of 0.39% is competitive, allowing investors to keep more of their returns.
Negative Factors
Underperforming Holdings
Some major holdings, including Merck, Comcast, and Salesforce, have lagged in year-to-date performance, potentially dragging on the fund.
High U.S. Concentration
With nearly all assets invested in U.S. companies, the ETF lacks exposure to international markets, limiting geographic diversification.
Moderate Asset Size
While the fund has over $1.8 billion in assets, it may not have the scale of larger ETFs, which could impact liquidity and investor interest.
DSTL vs. SPDR S&P 500 ETF (SPY)
AUM1.80B
RegionNorth America
Expense Ratio0.39%
Beta0.74
IssuerDistillate
Inception DateOct 24, 2018
Dividend Yield1.43%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume105,474
30 Day Avg. Volume90,963
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
67.06Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering102
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DSTL Summary
The Distillate US Fundamental Stability & Value ETF (DSTL) is an investment fund that focuses on large U.S. companies with strong financial health and attractive valuations. It includes well-known names like Johnson & Johnson and AbbVie, and covers industries such as healthcare, technology, and consumer goods. This ETF is designed for investors looking for a mix of stability and growth potential, making it a good option for diversifying a portfolio with high-quality, large-cap stocks. However, new investors should be aware that the ETF’s performance can fluctuate with the overall stock market, which means its value may go up or down depending on economic conditions.
How much will it cost me?The expense ratio for the Distillate US Fundamental Stability & Value ETF (DSTL) is 0.39%, which means you’ll pay $3.90 per year for every $1,000 you invest. This is slightly higher than the average for passively managed ETFs because DSTL uses a strategic, rules-based approach to select financially stable and value-oriented large-cap U.S. companies.
What would affect this ETF?DSTL's focus on financially stable U.S. large-cap companies, particularly in sectors like healthcare and technology, positions it to benefit from advancements in medical innovation and tech growth. However, rising interest rates or economic slowdowns could negatively impact consumer spending and corporate earnings, affecting sectors like consumer cyclical and industrials. Regulatory changes in healthcare or technology could also influence the ETF's performance.
DSTL Top 10 Holdings
The Distillate US Fundamental Stability & Value ETF (DSTL) leans heavily into health care and technology, with names like Johnson & Johnson and Cisco Systems providing steady contributions thanks to robust financial performance and strategic innovation. AbbVie is rising on strong earnings momentum, while Merck’s mixed results reflect competitive pressures. On the flip side, consumer-focused stocks like Procter & Gamble and Comcast are lagging, weighed down by macroeconomic challenges and slowing growth. With its U.S.-centric portfolio and focus on large-cap stability, DSTL is a thoughtful pick for value-driven investors seeking resilience in uncertain markets.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 2.88% | $51.79M | $472.05B | 28.95% | 78 Outperform | |
| AbbVie | 2.76% | $49.63M | $410.67B | 40.73% | 62 Neutral | |
| Merck & Company | 2.73% | $48.96M | $230.63B | -3.83% | 78 Outperform | |
| Cisco Systems | 2.35% | $42.26M | $308.35B | 35.72% | 77 Outperform | |
| T Mobile US | 2.10% | $37.63M | $241.69B | -8.94% | 73 Outperform | |
| Procter & Gamble | 1.96% | $35.21M | $345.07B | -14.60% | 74 Outperform | |
| Salesforce | 1.79% | $32.07M | $231.96B | -26.44% | 79 Outperform | |
| Comcast | 1.76% | $31.59M | $100.24B | -36.70% | 69 Neutral | |
| Qualcomm | 1.70% | $30.56M | $186.33B | 1.37% | 80 Outperform | |
| Amgen | 1.59% | $28.61M | $181.33B | 22.58% | 77 Outperform |
DSTL Technical Analysis
Negative
―
Price Trends
57.49
Negative
56.75
Positive
55.20
Positive
Market Momentum
-0.13
Negative
44.78
Neutral
52.98
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DSTL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 57.32, equal to the 50-day MA of 57.49, and equal to the 200-day MA of 55.20, indicating a neutral trend. The MACD of -0.13 indicates Negative momentum. The RSI at 44.78 is Neutral, neither overbought nor oversold. The STOCH value of 52.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DSTL.
DSTL Peer Comparison
Comparison Results
Performance Comparison
DSTL
Distillate US Fundamental Stability & Value ETF
56.78
1.20
2.16%
AVLV
Avantis U.S. Large Cap Value ETF
―
―
―
PVAL
Putnam Focused Large Cap Value ETF
―
―
―
JAVA
JPMorgan Active Value ETF
―
―
―
DFLV
Dimensional US Large Cap Value ETF
―
―
―
FELV
Fidelity Enhanced Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents